CAS RN: 573968-16-8
“(4S,4’S)-2,2′-Cyclopropylidenebis[4,5-dihydro-4-phenyloxazole],99%e.e.”
Product Availability
Choose a grade to view its available package options.
4 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260216 |
10mg |
Out of stock |
| Inquiry |
| Batchno.20251031 |
25mg |
Out of stock |
| Inquiry |
| Batchno.20260402 |
50mg |
Out of stock |
| Inquiry |
| Batchno.20250614 |
5mg / 10mg / 50mg |
Confirm by inquiry |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: >95%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 573968-16-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>95% |
1
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>95% |
1
In Stock
|
Shanghai |
Inquiry |
| 1g |
>95% |
1
In Stock
|
Hong Kong |
Inquiry |
573968-16-8 / (4S)-4-phenyl-2-[1-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopropyl]-4,5-dihydro-1,3-oxazole
Standard CAS: 573968-16-8
Multi CAS: Yes
Basic Information
CAS
573968-16-8
Multi CAS
Yes
Molecular Formula
C21H20N2O2
Molecular Weight
332.400000
Exact Mass
332.152478
InChI
InChI=1S/C21H20N2O2/c1-3-7-15(8-4-1)17-13-24-19(22-17)21(11-12-21)20-23-18(14-25-20)16-9-5-2-6-10-16/h1-10,17-18H,11-14H2/t17-,18-/m1/s1
InChIKey
ABUFHURHLVHRQG-QZTJIDSGSA-N
Computed Properties
Structural Parameters
Heavy atom count
25
Aromatic heavy atom count
12
Fraction Csp3
0.33
Rotatable bonds
4
H-bond acceptors
4
Molar refractivity
96.81
TPSA
43.18
LogP / Solubility
WLOGP
4.11
MLOGP
3.63
XLogP3
3.2
Consensus LogP
3.65
Log S (ESOL)
-4.58
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.25
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.71
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.83
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4.5